The steadily growing menu of the ADVIA® 1650 has a new addition, Cholinesterase.
The ADVIA Cholinesterase assay is an in-vitro diagnostic device intended to measure cholinesterase enzyme activity in human serum and plasma (lithium heparin) on the ADVIA chemistry systems.
This cholinesterase method is based on the method of Knedal and Bottger.
Cholinesterase catalyzes the hydrolysis of butyrylthiocholine to butyrate and thiocholine; the latter reduces 5,5'-dithiobis(2-nitrobenzoic acid) to 5-thio-2-nitrobenzoate. The increase in absorbance at 410 nm is proportional to the cholinesterase activity in the sample.
The reagents are provided in the package size as listed below. Components of the package are available as a kit only.
| Prod. No. | Contains | Amount (mL) | # of Tests |
|---|---|---|---|
| B01-4605-01 | Cholinesterase Reagents | R1: 4 x 205 | 4 x 133 |
| R2: 4 x 115 | 4 x 133 |
The expected values for this method are 4,900 U/L to 11,900 U/L. This range is provided for reference only. As with all diagnostics tests, each laboratory should establish its own normal range.
Data were collected on two (2) ADVIA 1650 chemistry systems. Imprecision estimates were obtained on commercially available control materials. Each sample was assayed two (2) times per run, one or two runs, for least 16 days. Imprecision estimates were computed according to NCCLS document EP5-A, Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline.
| Total | Within-run | ||
|---|---|---|---|
| Specimen Type | Level | SD | CV(%) |
| Serum Control 1 | 4236 | 47.0 | 1.1 |
| Serum Control 2 | 4686 | 54.9 | 1.2 |
This method is linear from 1,500 U/L to 30,000 U/L for serum and plasma.